Results 1 to 10 of about 4,679,298 (290)

Antiviral Drugs in Influenza [PDF]

open access: yesInternational Journal of Environmental Research and Public Health, 2022
Flu is a serious health, medical, and economic problem, but no therapy is yet available that has satisfactory results and reduces the occurrence of these problems. Nearly 20 years after the registration of the previous therapy, baloxavir marboxil, a drug
M. Świerczyńska   +2 more
semanticscholar   +3 more sources

Stability and WBE biomarkers possibility of 17 antiviral drugs in sewage and gravity sewers

open access: yesWater Research, 2023
Wastewater-based epidemiology (WBE) is a promising technique for monitoring the rapidly increasing use of antiviral drugs during the COVID-19 pandemic.
Qian Dong, Yanchen Liu
exaly   +2 more sources

Association of antiviral drugs and their possible mechanisms with DRESS syndrome using data mining algorithms

open access: yesJournal of Medical Virology, 2023
Antiviral drugs are not known for drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome. The current study aims is to find out the association of antiviral drugs and their possible mechanism with DRESS.
Akash Sharma   +3 more
exaly   +2 more sources

Trends and strategies to combat viral infections: A review on FDA approved antiviral drugs

open access: yesInternational Journal of Biological Macromolecules, 2021
The infectious microscopic viruses invade living cells to reproduce themselves, and causes chronic infections such as HIV/AIDS, hepatitis B and C, flu, etc. in humans which may lead to death if not treated.
Saraboji Kadhirvel
exaly   +2 more sources

A sustainable approach for the removal methods and analytical determination methods of antiviral drugs from water/wastewater: A review

open access: yesJournal of Water Process Engineering, 2022
In the last years, antiviral drugs especially used for the treatment of COVID-19 have been considered emerging contaminants because of their continuous occurrence and persistence in water/wastewater even at low concentrations. Furthermore, as compared to
Ismail Koyuncu
exaly   +2 more sources

Pharmacology of Antiviral Drugs. [PDF]

open access: yesViruses
Antiviral drug therapy has significantly evolved over the past four decades, partly driven by improved understanding of viral replication mechanisms but also advances in pharmacology and formulation technologies [...]
Martin DE.
europepmc   +4 more sources

Antiviral Drugs for EBV [PDF]

open access: yesCancers, 2018
Epstein–Barr virus (EBV) infects up to 95% of the adult human population, with primary infection typically occurring during childhood and usually asymptomatic.
J. Pagano   +2 more
semanticscholar   +4 more sources

Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results

open access: yesNew England Journal of Medicine, 2020
Background World Health Organization expert groups recommended mortality trials of four repurposed antiviral drugs — remdesivir, hydroxychloroquine, lopinavir, and interferon beta-1a — in patients hospitalized with coronavirus disease 2019 (Covid-19 ...
H. Pan   +73 more
semanticscholar   +2 more sources

Monkeypox (mpox) virus: Classification, origin, transmission, genome organization, antiviral drugs, and molecular diagnosis

open access: yesJournal of Infection and Public Health, 2023
Monkeypox virus (MPXV) is a double-stranded DNA virus belonging to the Poxviridae family of the genus Orthopoxvirus with two different clades known as West African and Congo Basin.
Aysel Karagoz   +9 more
semanticscholar   +1 more source

Molnupiravir and Nirmatrelvir-Ritonavir: Oral COVID Antiviral Drugs

open access: yesClinical Infectious Diseases, 2022
At a crucial time with rapid spread of Omicron SARS-CoV-2 virus variant globally, the United States Food and Drug Administration has issued an emergency use authorization for two oral antivirals molnupiravir (>18 years) and nirmatrelvir-ritonavir ...
L. Saravolatz   +2 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy